October 18, 2022

Global Brain has invested in Metalenz, Inc., the first fabless semiconductor optics company, revolutionizing optical sensing

Global Brain has invested in Metalenz, Inc. (Metalenz), a pioneer in the metasurfaces space and the first company to commercialize meta-optics, through its GB-VIII Growth Fund Investment Limited Partnership (GB-VIII).

Metalenz, founded in 2016, is the first company to commercialize meta-optics. With exclusive worldwide license to the portfolio of foundational intellectual property relating to metasurfaces developed in the Capasso Lab at Harvard University, Metalenz has more than 20 patents on innovations that simplify and improve optical devices across multiple markets. The company’s meta-surface technology provides complex, multifunctional optical performance in a single semiconductor layer, relocating large-scale production of optics to semiconductor foundries.

Their technology produces incredibly compact, lower cost (simpler) optic modules and superior performance (better & brighter images) for many camera applications including mobile devices, AR/VR and automotive.

Global Brain has highly recognized the first mover advantage and the foundational IPs of Metalenz technology and decided to invest in Metalenz. Global Brain will support Metalenz’s business development in Japan.

About Metalenz

Location
Boston, USA
CEO
Rob Devlin, Ph. D.
Founded
October 2016
URL
https://www.metalenz.com/

About GB-VIII

Name
GB-VIII Growth Fund Investment Limited Partnership
General Partner
Global Brain Corporation

About Global Brain

Location
Tokyo, Japan
Representative
Yasuhiko Yurimoto
Founded
January 1998
URL
https://globalbrains.com/

The Global Brain mark is a registered trademark of Global Brain Corporation. Other marks and trade names are the property of their respective owners.

© 2023 Global Brain Corporation